Literature DB >> 11171057

Phosphorylation and desensitization of alpha1d-adrenergic receptors.

J A García-Sáinz1, F G Vázquez-Cuevas, M T Romero-Avila.   

Abstract

In rat-1 fibroblasts stably expressing rat alpha(1d)-adrenoceptors, noradrenaline and PMA markedly decreased alpha(1d)-adrenoceptor function (noradrenaline-elicited increases in calcium in whole cells and [(35)S]guanosine 5'-[gamma-thio]triphosphate binding in membranes), suggesting homologous and heterologous desensitizations. Photoaffinity labelling, Western blotting and immunoprecipitation identified alpha(1d)-adrenoceptors as a broad band of 70-80 kDa. alpha(1d)-Adrenoceptors were phosphorylated in the basal state and noradrenaline and PMA increased it. The effect of noradrenaline was concentration-dependent (EC(50) 75 nM), rapid (maximum at 1 min) and transient. Phorbol ester-induced phosphorylation was concentration-dependent (EC(50) 25 nM), slightly slower (maximum at 5 min) and stable for at least 60 min. Inhibitors of protein kinase C decreased the effect of phorbol esters but not that of noradrenaline. Evidence of cross-talk of alpha(1d)-adrenoceptors with receptors endogenously expressed in rat-1 fibroblasts was given by the ability of endothelin, lysophosphatidic acid and bradykinin to induce alpha(1d)-adrenoceptor phosphorylation. In summary, it is shown for the first time here that alpha(1d)-adrenoceptors are phosphoproteins and that receptor phosphorylation is increased by the natural ligand, noradrenaline, by direct activation of protein kinase C and via cross-talk with other receptors endogenously expressed in rat-1 fibroblasts. Receptor phosphorylation has functional repercussions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171057      PMCID: PMC1221606          DOI: 10.1042/0264-6021:3530603

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Functional evidence of alpha1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats.

Authors:  R Villalobos-Molina; J J López-Guerrero; M Ibarra
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.

Authors:  D M Perez; M T Piascik; R M Graham
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

3.  Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype.

Authors:  D A Schwinn; J W Lomasney; W Lorenz; P J Szklut; R T Fremeau; T L Yang-Feng; M G Caron; R J Lefkowitz; S Cotecchia
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

4.  Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor.

Authors:  S Cotecchia; D A Schwinn; R R Randall; R J Lefkowitz; M G Caron; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Differential desensitization and phosphorylation of three cloned and transfected alpha 2-adrenergic receptor subtypes.

Authors:  H Kurose; R J Lefkowitz
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

6.  Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5.

Authors:  J W Lomasney; S Cotecchia; W Lorenz; W Y Leung; D A Schwinn; T L Yang-Feng; M Brownstein; R J Lefkowitz; M G Caron
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

7.  The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy.

Authors:  K U Knowlton; M C Michel; M Itani; H E Shubeita; K Ishihara; J H Brown; K R Chien
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

8.  Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.

Authors:  S B Liggett; N J Freedman; D A Schwinn; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism.

Authors:  L M Leeb-Lundberg; S Cotecchia; J W Lomasney; J F DeBernardis; R J Lefkowitz; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Sites in the third intracellular loop of the alpha 2A-adrenergic receptor confer short term agonist-promoted desensitization. Evidence for a receptor kinase-mediated mechanism.

Authors:  S B Liggett; J Ostrowski; L C Chesnut; H Kurose; J R Raymond; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

View more
  9 in total

1.  Roles of the α1A-adrenergic receptor carboxyl tail in protein kinase C-induced phosphorylation and desensitization.

Authors:  Alejandro Cabrera-Wrooman; María Teresa Romero-Ávila; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-05       Impact factor: 3.000

2.  Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease.

Authors:  U B Schambra; G B Mackensen; M Stafford-Smith; D E Haines; D A Schwinn
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Signaling properties of human alpha(1D)-adrenoceptors lacking the carboxyl terminus: intrinsic activity, agonist-mediated activation, and desensitization.

Authors:  C Ekaterina Rodríguez-Pérez; M Teresa Romero-Avila; Guadalupe Reyes-Cruz; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-21       Impact factor: 3.000

Review 4.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

5.  Vascular alpha-1D-adrenoceptors are overexpressed in aorta of the aryl hydrocarbon receptor null mouse: role of increased angiotensin II.

Authors:  R Villalobos-Molina; F G Vázquez-Cuevas; J J López-Guerrero; M C Figueroa-García; I A Gallardo-Ortiz; M Ibarra; M Rodríguez-Sosa; F J Gonzalez; G Elizondo
Journal:  Auton Autacoid Pharmacol       Date:  2008 Apr-Jul

6.  Carboxyl terminus-truncated α1D-adrenoceptors inhibit the ERK pathway.

Authors:  Marco A Alfonzo-Méndez; Jean A Castillo-Badillo; M Teresa Romero-Ávila; Richard Rivera; Jerold Chun; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-05       Impact factor: 3.000

7.  Influence of combined hypertension and renal failure on functional alpha(1)-adrenoceptor subtypes in the rat kidney.

Authors:  M A Hye Khan; M A Sattar; N A Abdullah; E J Johns
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

Review 8.  Novel Structural Approaches to Study GPCR Regulation.

Authors:  Marco A Alfonzo-Méndez; Rocío Alcántara-Hernández; J Adolfo García-Sáinz
Journal:  Int J Mol Sci       Date:  2016-12-23       Impact factor: 5.923

Review 9.  Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.